Webinar Overview

Safety pharmacology integrated toxicology studies have recently become an accepted method to collect data associated with test articles in preclinical development. Prior to running these studies, it’s crucial to discuss a proper study design that can reduce the need for animal models, assess multiple dose administrations, and directly compare standard toxicology endpoints to ensure the collection of meaningful data and meet study objectives.

This webinar examines when to incorporate safety pharmacology into toxicology studies, general considerations regarding study design, and any regulatory issues that may come up.

 

Webinar Presenters

Stephen D. Tichenor, PhD
Associate Director, Safety Pharmacology
Charles River


Aileen Milne, PhD
Associate Director, Safety Pharmacology
Charles River

 

We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.